Profil
Vincent J.
O'Neill is currently a Member at The Royal College of Physicians and Senior VP, Chief Research & Development Officer at OnkosXcel Therapeutics LLC.
Former positions include EVP, Chief Medical & Product Development Officer at BioXcel Therapeutics, Inc. from 2017 to 2025; Chief Medical Officer at Mirna Therapeutics, Inc. from 2016 to 2017; Chief Medical Officer at Exosome Diagnostics, Inc. from 2014 to 2016; Global Head-Personalized Medicine at Sanofi from 2012 to 2014; Group Director at Genentech, Inc. from 2009 to 2012; and Director-Discovery Medicine at GSK Plc from 2006 to 2009.
Education was completed at the University of Glasgow with graduate and doctorate degrees.
Postes actifs de Vincent O'Neill
| Sociétés | Poste | Début |
|---|---|---|
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
OnkosXcel Therapeutics LLC
OnkosXcel Therapeutics LLC Medical/Nursing ServicesHealth Services Operates as oncology clinic | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Vincent O'Neill
| Sociétés | Poste | Fin |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2025 |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Directeur Technique/Scientifique/R&D | 19/05/2017 |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Directeur Technique/Scientifique/R&D | 01/05/2016 |
| SANOFI | Corporate Officer/Principal | 01/05/2014 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur/Membre du Conseil | 01/06/2012 |
Formation de Vincent O'Neill
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Commercial Services |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Health Services |
BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
OnkosXcel Therapeutics LLC
OnkosXcel Therapeutics LLC Medical/Nursing ServicesHealth Services Operates as oncology clinic | Health Services |
















